Literature DB >> 10715380

A 10-year review of penetrating keratoplasty.

K Inoue1, S Amano, T Oshika, M Sawa, T Tsuru.   

Abstract

PURPOSE: To survey the changes in indications for penetrating keratoplasty (PKP) and re-evaluate the risk factors for allograft rejection and graft failure.
METHODS: We evaluated the records of 396 eyes of 335 patients who had undergone PKP at the Tokyo University Hospital between 1987 and 1997. Clinical results were analyzed by the Kaplan-Meier life table method and the log-rank test.
RESULTS: The overall rates of graft survival and rejection-free graft survival at 10 years were 72.2% and 76.8%, respectively. The rates of graft survival and rejection-free graft survival were 98.8% and 86.6% in keratoconus, 87.0% and 56.5% in herpetic keratitis, 76.9% and 73.1% in corneal dystrophy and degeneration, 69.4% and 80.6% in nonherpetic keratitis, 62.5% and 75.0% in chemical burns, 61.8% and 72.1% in regrafting, and 51.1% and 79.8% in bullous keratopathy, respectively. The graft survival rates were statistically higher in the PKP alone group than in the combined operation group. The graft survival and rejection-free graft survival rates were statistically higher in the first operation group than in the regrafted group, and in the avascular cornea group than in the vascular cornea group.
CONCLUSIONS: We recognized changes in indications for PKP. Combined operation, reoperation, and vascularization of recipient cornea were risk factors for graft failure.

Entities:  

Mesh:

Year:  2000        PMID: 10715380     DOI: 10.1016/s0021-5155(99)00190-2

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  15 in total

Review 1.  Graft failure IV. Immunologic mechanisms of corneal transplant rejection.

Authors:  Eva-Marie Chong; M Reza Dana
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

2.  Visual outcome in corneal grafts: a preliminary analysis of the Swedish Corneal Transplant Register.

Authors:  M Claesson; W J Armitage; P Fagerholm; U Stenevi
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

3.  3D in vitro model for human corneal endothelial cell maturation.

Authors:  Audrey E K Hutcheon; James D Zieske; Xiaoqing Guo
Journal:  Exp Eye Res       Date:  2019-04-10       Impact factor: 3.467

4.  Twelve-year follow-up of penetrating keratoplasty.

Authors:  Takashi Ono; Sosuke Ishiyama; Takeshi Hayashidera; Yosai Mori; Ryohei Nejima; Kazunori Miyata; Shiro Amano
Journal:  Jpn J Ophthalmol       Date:  2016-11-24       Impact factor: 2.447

5.  Penetrating keratoplasty for keratoconus: visual and graft survival outcomes.

Authors:  Mansour M Al-Mohaimeed
Journal:  Int J Health Sci (Qassim)       Date:  2013-01

6.  Characteristics and risk factors of recurrent keratoconus over the long term after penetrating keratoplasty.

Authors:  Junko Yoshida; Hiroshi Murata; Takashi Miyai; Rika Shirakawa; Tetsuya Toyono; Satoru Yamagami; Tomohiko Usui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-09-08       Impact factor: 3.117

7.  Outcome of primary adult optical penetrating keratoplasty with imported donor corneas.

Authors:  Michael D Wagoner; El-Sayed Gonnah; Abdul-Elah Al-Towerki
Journal:  Int Ophthalmol       Date:  2009-01-23       Impact factor: 2.031

8.  Outcomes of the Boston keratoprosthesis in jordan.

Authors:  Wisam A Shihadeh; Hasan M Mohidat
Journal:  Middle East Afr J Ophthalmol       Date:  2012-01

9.  Changing indications and surgical techniques for corneal transplantation between 2004 and 2009 at a tertiary referral center.

Authors:  Mohammad Zare; Mohammad A Javadi; Bahram Einollahi; Farid Karimian; Ali R B Rafie; Sepehr Feizi; Ahmad Azimzadeh
Journal:  Middle East Afr J Ophthalmol       Date:  2012 Jul-Sep

10.  Ipsilateral rotational autokeratoplasty for the management of traumatic corneal scar.

Authors:  Alime Günes; Tahir Kansu Bozkurt; Cihan Unlu; Betül Ilkay Sezgin Akcay; Hüseyin Bayramlar
Journal:  Case Rep Ophthalmol Med       Date:  2012-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.